C1389
羧苄青霉素 二钠盐
89.0-100.5% anhydrous basis
别名:
羧苄青霉素二钠, α-Carboxybenzylpenicillin disodium salt 二钠盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C17H16N2Na2O6S
化学文摘社编号:
分子量:
422.36
UNSPSC Code:
51282413
NACRES:
NA.76
PubChem Substance ID:
EC Number:
225-360-8
Beilstein/REAXYS Number:
5722128
MDL number:
InChI key
RTYJTGSCYUUYAL-YCAHSCEMSA-L
InChI
1S/C17H18N2O6S.2Na/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8;;/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25);;/q;2*+1/p-2/t9?,10-,11+,14-;;/m1../s1
SMILES string
[Na+].[Na+].CC1(C)S[C@@H]2[C@H](NC(=O)C(C([O-])=O)c3ccccc3)C(=O)N2[C@H]1C([O-])=O
biological source
synthetic (chemical)
assay
89.0-100.5% anhydrous basis
form
powder
color
white to off-white
solubility
H2O: 50 mg/mL
antibiotic activity spectrum
Gram-negative bacteria, Gram-positive bacteria
mode of action
cell wall synthesis | interferes
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
羧苄青霉素是一种半合成、广谱羧基青霉素抗生素，具有杀菌和抗β－内酰胺酶活性。它是一种广谱抗生素，即它能够有效对抗各种细菌，包括革兰氏阳性和革兰氏阴性细菌。羧苄青霉素对铜绿假单胞菌特别有效，铜绿假单胞菌是一种可以耐受其它抗生素的革兰氏阴性菌。
羧苄青霉素常用于细胞生物学应用，可防止细菌污染物的生长。在微生物学中，它也用于选择以含有编码β－内酰胺酶基因的载体转化的细菌，这使其耐受羧苄青霉素。
羧苄青霉素常用于细胞生物学应用，可防止细菌污染物的生长。在微生物学中，它也用于选择以含有编码β－内酰胺酶基因的载体转化的细菌，这使其耐受羧苄青霉素。
Application
羧苄青霉素二钠盐已用于：
- 制备LB琼脂平板和培养基
- 作为培养基中的选择剂用于防止细菌污染物的生长
- 开发单克隆抗体的研究
Biochem/physiol Actions
作用机制：羧青霉素抗生素，可通过灭活细菌细胞膜内表面的转肽酶来抑制细菌细胞壁合成（肽聚糖交联）。
抗微生物谱：具有抗革兰氏阳性和革兰氏阴性细菌活性。
抗微生物谱：具有抗革兰氏阳性和革兰氏阴性细菌活性。
羧苄青霉素通过打开内酰胺环，酰化青霉素敏感性转肽酶（penicillin-sensitive transpeptidase）的C-末端结构域。这种钝化作用防止了肽聚糖束（peptidoglycan strand）的交联，从而抑制了细菌细胞壁合成的第三和最后阶段。这导致细菌细胞壁的不完全合成，最终导致细胞溶解。
Features and Benefits
- 具有杀菌和抗β－内酰胺酶活性的广谱抗生素
- 有效对抗各种细菌，包括铜绿假单胞菌
- 常用于细胞生物学和生物化学应用
- 提供优于氨苄青霉素的稳定性
Preparation Note
密闭。干燥。上锁保存或放置在只有经过授权或有资质的人员才能进入的区域。
Analysis Note
在 37°C 下可稳定保存 3 天
signalword
Danger
hcodes
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
涉药品监管产品
此项目有
Sua Lee et al.
Frontiers in immunology, 12, 778829-778829 (2021-12-07)
Since the coronavirus disease outbreak in 2019, several antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Antibody therapeutics are effective in neutralizing the virus and reducing hospitalization in patients with mild and moderate
Benjamin Bardiaux et al.
Structure (London, England : 1993), 27(7), 1082-1093 (2019-05-06)
Bacterial type 4a pili are dynamic surface filaments that promote bacterial adherence, motility, and macromolecular transport. Their genes are highly conserved among enterobacteria and their expression in enterohemorrhagic Escherichia coli (EHEC) promotes adhesion to intestinal epithelia and pro-inflammatory signaling. To
Catherine Kaminski et al.
Critical care (London, England), 15(2), R112-R112 (2011-04-13)
Although Pseudomonas aeruginosa is a leading pathogen responsible for ventilator-associated pneumonia (VAP), the excess in mortality associated with multi-resistance in patients with P. aeruginosa VAP (PA-VAP), taking into account confounders such as treatment adequacy and prior length of stay in
Jiachuan Pan et al.
PloS one, 7(9), e45778-e45778 (2012-10-03)
Bacteria are well known to form dormant persister cells that are tolerant to most antibiotics. Such intrinsic tolerance also facilitates the development of multidrug resistance through acquired mechanisms. Thus persister cells are a promising target for developing more effective methods
J Steinmann et al.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 16(33) (2011-08-30)
We describe the epidemiology and characteristics of the pathogen and patients (n=7) associated with an outbreak of a carbapenem-resistant Klebsiella pneumoniae (CRKP) strain in a German university hospital from July 2010 to January 2011. Species identification and detection of carbapenem
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持